Wearable non-invasive neuroprosthesis for targeted sensory restoration in neuropathy.
Noemi Gozzi, Lauren Chee, Ingrid Odermatt...
https://pubmed.ncbi.nlm.nih.gov/39738088/Actively Recruiting
Led by MYNERVA AG · Updated on 2026-07-15
80
Participants Needed
3
Research Sites
82 weeks
Total Duration
Researchers are evaluating a wearable device designed to support balance and walking in adults with peripheral neuropathy. This trial aims to assess whether the device can improve gait stability and balance during daily activities while also examining its safety, comfort, and overall user acceptability. The study compares an active device with a sham inactive version in a controlled, randomized setting. Participants will be randomly assigned to use either the active wearable device or a sham device that lacks active functionality. They will use the device over a defined period to evaluate changes in gait and balance. The study includes weekly sessions and a home-use phase to monitor device performance and user experience. Both groups will be observed and assessed throughout the study to compare outcomes. Participants will attend weekly visits and perform home use of the device, with follow-up assessments up to 80 days. Researchers will measure changes in the Functional Gait Assessment score, timed-up-and-go test, neuropathic pain symptoms, quality of life, sensory function tests, fall risk, neuroimaging in some participants, and objective gait parameters like step length and heel-strike force. Treatment compliance and device usability will also be monitored to evaluate safety and effectiveness over the study period.
CONDITIONS
Randomized, Sham-Controlled Investigation of the Leia Sensory Prosthesis in Individuals With Peripheral Neuropathy
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
MYNERVA AG
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 56 days (8 weeks)
Participants use either the active wearable device or a sham device during the study period. They attend weekly sessions and perform home use of the device.
Weekly visits and home use
Duration - Up to 24 days after treatment ends
Participants return for follow-up assessments to measure changes in balance, gait, pain, quality of life, and sensory function.
Follow-up visits at day 56 and day 80
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Noemi Gozzi, Lauren Chee, Ingrid Odermatt...
https://pubmed.ncbi.nlm.nih.gov/39738088/MYNERVA AG
Lead Sponsor